JPMorgan Starts PharMerica (PMC) at Market Outperform
More News related to PMC
- PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference
- PharMerica to Present at the Oppenheimer 20th Annual Healthcare Conference
- PharMerica (PMC) Tops Q3 EPS by 16c; Guides In-Line
- PharMerica Reports Results for the Third Quarter of 2009 and Nine Months Ended September 30, 2009
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to New Coverage
- Morgan Stanley Starts ONEOK (OKE) at Underweight, $40 Price Target
- Broadpoint.Amtech Initiates Coverage on Willbros Group (WG) with a Buy; Leading North American Pipeline Contractor
- Miller Tabak Initiates Coverage on Oclaro (OCLR) with a Buy
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
- Craig-Hallum Initiates Coverage on Onyx Pharmaceuticals (ONXX) with a Buy
JPMorgan initiates coverage on PharMerica Corp. (NYSE: PMC) with a Market Outperform rating.
PharMerica Corporation operates as an institutional pharmacy services company in the United States.
Related Categories
New CoverageStocks Mentioned
+0.22Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
